Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 305

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Sertraline versus other antidepressive agents for depression

Cipriani, Andrea, La Ferla, Teresa, Furukawa, Toshi A, Signoretti, Alessandra, Nakagawa, Atsuo, Churchill, Rachel, McGuire, Hugh, Barbui, Corrado · 2009 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: The National Institute for Health and Clinical Excellence clinical practice guideline on the treatment of depressive disorder recommended that selective serotonin reuptake inhibitors should be the first-line option when drug therapy is indicated for a depressive episode. Preliminary evidence suggested that sertraline might be slightly superior in terms of effectiveness. OBJECTIVES: To assess the evidence for the efficacy, acceptability and tolerability of escitalopram in comparison with tricyclics (TCAs), heterocyclics, other SSRIs and newer agents in the acute-phase treatment of major depression. SEARCH STRATEGY: MEDLINE (1966 to 2008), EMBASE (1974 to 2008), the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register and the Cochrane Central Register of Controlled Trials up to July 2008. No language restriction was applied. Reference lists of relevant papers and previous systematic reviews were hand-searched. Pharmaceutical companies and experts in this field were contacted for supplemental data. SELECTION CRITERIA: Randomised controlled trials allocating patients with major depression to sertraline versus any other antidepressive agent. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. Discrepancies were resolved with another member of the team. A double-entry procedure was employed by two reviewers. Information extracted included study characteristics, participant characteristics, intervention details and outcome measures in terms of efficacy (the number of patients who responded or remitted), acceptability (the number of patients who failed to complete the study) and tolerability (side-effects). MAIN RESULTS: A total of 59 studies, mostly of low quality, were included in the review, involving multiple treatment comparisons between sertraline and other antidepressant agents. Evidence favouring sertraline over some other antidepressants for the acute phase treatment of major depression was found, either in terms of efficacy (fluoxetine) or acceptability/tolerability (amitriptyline, imipramine, paroxetine and mirtazapine). However, some differences favouring newer antidepressants in terms of efficacy (mirtazapine) and acceptability (bupropion) were also found. In terms of individual side effects, sertraline was generally associated with a higher rate of participants experiencing diarrhoea. AUTHORS' CONCLUSIONS: This systematic review and meta-analysis highlighted a trend in favour of sertraline over other antidepressive agents both in terms of efficacy and acceptability, using 95% confidence intervals and a conservative approach, with a random effects analysis. However, the included studies did not report on all the outcomes that were pre-specified in the protocol of this review. Outcomes of clear relevance to patients and clinicians were not reported in any of the included studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd006117.pub2

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 111 references

Research works printed but not linked: 23

  1. Khoury, 1998, Effect of sertraline and paroxetine treatment on depression scores and peripheral indices of serotonergic function in major depression, 11th European College of Neuropsychopharmacology Congress. Paris, France. 31st October 4th November 1998
  2. Behan, 1995, 5-HT reuptake inhibitors in CFS, EOS Rivista di Immunologia ed Immunofarmacologia, 15, 66
  3. Cohn, 1990, Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry, 51, 28
  4. Fournier, 1997, A double-blind comparison of sertraline and imipramine in outpatients with major depression: Acute (8 weeks) and continuation (16 weeks) treatment, Human Psychopharmacology, 12, 203, 10.1002/(SICI)1099-1077(199705/06)12:3<203::AID-HUP849>3.0.CO;2-V · doi:10.1002/(sici)1099-1077(199705/06)12:3<203::aid-hup849>3.0.co;2-v
  5. Hegerl, 1997, Sertraline versus amitriptyline in hospitalized patients with major depression, Pharmacopsychiatry, 30, 175
  6. Kamijima, 1997, A double-blind, group comparison study of sertraline by hydrochloride vs amitriptyline hydrochloride, Japanese Journal of Neuropsychopharmacology, 19, 529
  7. Lee, 1994, Efficacy of sertraline in dysthymia, Neuropsychopharmacology, 10, 222S
  8. Li, 2001, A comparative study of sertraline and maprotiline in the treatment of depression, Shandong Journal of Psychological Medicine, 14, 173
  9. Murasaki, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for depression and depressive state-A double-blind study compared with imipramine hydrochloride, Japanese Journal of Meuropsychopharmacology, 19, 505
  10. Tsutsui, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of depression and depressive state: a double-blind, group comparison study of sertraline hydrochloride vs trazodone hydrochloride, Shinkeiseishinyakuri, 19, 549
  11. Gonul, 1999, Selective serotonin reuptake inhibitors: discontinuation rates due to side effects, European Neuropsychopharmacology, 9, 215, 10.1016/S0924-977X(99)80132-1 · doi:10.1016/s0924-977x(99)80132-1
  12. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III) 3rd Edition Washington, DC American Psychiatric Association
  13. 1987, Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
  14. 1994, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
  15. Cipriani, 2007, Escitalopram versus other antidepressive agents for depression. (Protocol), Cochrane Database of Systematic Reviews
  16. Geddes, 2000, Selective serotonin reuptake inhibitors (SSRIs) for depression, Cochrane Database of Systematic Reviews
  17. Geddes, 2004, Depressive disorders, Clinical Evidence, 12, 1391
  18. Guy, 1970, Manual for the ECDEU Assessment Battery.2
  19. 2004, Depression: management of depression in primary and secondary care
  20. 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
  21. 1982, The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)
  22. 2001, World Health Report 2001: Mental Health: New Understanding, New Hope
  23. Wing, 1994, Measuring mental health outcomes: a perspective from the Royal College of Psychiatrists. Outcomes into Clinical Practice. London:

Cited by

See all 305

Metadata

Authors
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C.
Venue
Cochrane Database of Systematic Reviews
Published
2009-04-15
Issue
2
Pages
CD006117-CD006117
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4243810801
Cited by
305
References
111
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sertraline versus other antidepressive agents for depression. https://app.cochat.ai/papers/10.1002/14651858.cd006117.pub2
The paper
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2009). Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd006117.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.